Number of respondents (% of all respondents) | Number of PCPs invited | Response rate (%) | 1-year relative cancer survival* (%) | 5-year relative cancer survival* (%) | |
Respondents per country (in alphabetical order) | |||||
Bulgaria | 59 (2.8) | 90 | 65.6 | 59.6 | 38.4 |
Croatia | 67 (3.2) | 292 | 22.9 | 63.7 | 44.7 |
Denmark | 107 (5.1) | 400 | 26.8 | 69.0 | 45.4 |
England | 65 (3.1) | 300 | 21.7 | 65.2 | 42.7 |
Finland | 65 (3.1) | 178 | 36.5 | 73.2 | 50.3 |
France | 59 (2.8) | 550 | 10.7 | 74.9 | 49.8 |
Germany | 103 (4.9) | 242 | 42.6 | 73.5 | 50.3 |
Greece | 68 (3.3) | 318 | 21.4 | Data not available | |
Israel | 75 (3.6) | 339 | 22.1 | 79.2† | 58.3† |
Italy | 63 (3.0) | 200 | 31.5 | 72.9 | 49.4 |
Netherlands | 113 (5.4) | 1601 | 7.1 | 72.0 | 49.1 |
Norway | 90 (4.3) | 500 | 18.0 | 72.8 | 49.9 |
Poland | 152 (7.3) | 422 | 36.0 | 65.8 | 41.5 |
Portugal | 65 (3.1) | 227 | 28.6 | 71.0 | 48.2 |
Romania | 177 (8.5) | Not known | Data not available | ||
Scotland | 65 (3.1) | 350 | 18.6 | 66.5 | 43.7 |
Slovenia | 104 (5.0) | 352 | 29.5 | 69.5 | 44.8 |
Spain | 446 (21.4) | Not known | 70.3 | 46.8 | |
Sweden | 79 (3.8) | 400 | 19.8 | 75.9 | 51.5 |
Switzerland | 64 (3.1) | 100 | 64.0 | 75.7 | 50.2 |
Total | 2086 (100) |
*Calculated using International Cancer Survival Standards (ICSS).
†Calculated from data provided by B. Silverman, Israel Ministry of Health (personal communication, 7 September 2017) and Y. Schonmann, London School of Hygiene & Tropical Medicine (personal communication, 7 September 2018).
PCPs, primary care practitioners.